iBio Inc is a biotechnology company. It is engaged in commercializing its proprietary platform technologies, iBioLaunch for vaccines and therapeutic proteins & iBioModulator for vaccine enhancement and developing select product candidates.
$2.02 -0.01 (-0.25%)
As of 02/24/2021 13:21:19 EST IEX book CBOE book
2021 © Stock Market MBA, Inc.